Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study

INTRODUCTION: Anticholinergic burden may be an important risk factor for the cognitive impairment. Especially in polypharmacy, even drugs with low anticholinergic effects may contribute to a significant anticholinergic burden. The drugs with anticholinergic effects are used in treatment of motor and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumbul-Sekerci, Betul, Bilgic, Basar, Pasin, Ozge, Emre, Murat, Hanagasi, Hasmet A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909708/
https://www.ncbi.nlm.nih.gov/pubmed/36273437
http://dx.doi.org/10.1159/000526863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909708/
https://www.ncbi.nlm.nih.gov/pubmed/36273437
http://dx.doi.org/10.1159/000526863

Ejemplares similares